Skip to content

Shivarajan Manickavasagam Amudhavalli, M.B.B.S.

NPI 1700021706ActiveIndividual· Medical Genetics, Clinical Genetics (M.D.)· Kansas City, MO

Medical Genetics, Clinical Genetics (M.D.) (M.B.B.S.) in Kansas City, Missouri, licensed in MO and KS, with an NPI issued in December 2008. Enrolled in Medicare as practitioner - pediatric medicine and practitioner - pediatric medicine. Biomarin Pharmaceutical Inc. reported $157.96 in payments in 2025, mostly food and beverage.

Overview

NPI1700021706
StatusActive
Entity typeIndividual
CredentialM.B.B.S.
Sole proprietorNo
NPI issuedDec 5, 2008
Last updated in NPPESJul 18, 2026
Certified by providerJul 18, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pediatric Medicine (KS); Practitioner - Pediatric Medicine (MO)

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$157.96 · 2 payments from 1 company
  • 2024$105.25 · 4 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Biomarin Pharmaceutical Inc.$157.962

What the 2025 payments were for

  • Food and Beverage$157.96 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Medical Genetics, Clinical Genetics (M.D.) providers in Kansas City

All Medical Genetics, Clinical Genetics (M.D.) providers in Missouri